Sterling, Timothy R <br/><br/>
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.  [electronic resource] 

 -  AIDS (London, England)  06 2016 
 - 1607-15 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0000000000001098  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Americas<br/>Antitubercular Agents--administration & dosage<br/>Asia<br/>Child<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>Isoniazid--administration & dosage<br/>Male<br/>Prospective Studies<br/>Rifampin--administration & dosage<br/>Treatment Outcome<br/>Tuberculosis--complications<br/>Young Adult